Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.1.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAGENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DJ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.11.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5 (Omicron)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BR.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.6.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.12.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LZ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KW.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KU.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.4.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used